![Stephen Willard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 609 669 $ al 31/05/2026
Stephen H.
Willard is currently Chief Executive Officer at Longeveron, Inc. since 2026.
Mr. Willard is also a Director at Global Life Technologies Corp.
and a Director at The National Science Board since 2018.
Formerly, Mr. Willard was Chief Executive Officer & Director at Cellphire, Inc. from 2013 to 2021, Chief Executive Officer & Secretary at NRX Pharmaceuticals, Inc. in 2024, Executive Director at Nozin, Inc. from 2021 to 2022, Non-Executive Chairman at Flamel Technologies SA from 2012 to 2014, Independent Director at E*TRADE Financial Corp.
from 2012 to 2014, Director at E*TRADE Bank from 2000 to 2014, Director at ETB Holdings, Inc. in 2005, Associate Director-Resolutions at Federal Deposit Insurance Corp.
from 1991 to 1994, Chief Executive Officer at Icapath, Inc., and President at Flamel Technologies, Inc. Education includes a graduate degree from Yale University conferred in 1985 and an undergraduate degree from Williams College conferred in 1982.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LONGEVERON INC. CLASS A 2,62 % | 01/05/2026 | 789.727 ( 2,62 % ) | 609 669 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LONGEVERON INC. | Director Ejecutivo | 11/02/2026 |
Global Life Technologies Corp.
 Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Miembro de la Junta | - |
The National Science Board | Director/Miembro de la Junta | 01/01/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Icapath, Inc.
 Icapath, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technology that combines PLGA nanoparticles | Director Ejecutivo | 01/10/2025 |
| NRX PHARMACEUTICALS, INC. | Director Ejecutivo | 11/10/2024 |
Cellphire, Inc.
 Cellphire, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops platelet-derived therapeutics | Director Ejecutivo | 01/03/2021 |
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Presidente | 02/07/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
E*TRADE Financial Corp.
 E*TRADE Financial Corp. Investment Banks/BrokersFinance Provides online stock brokerage and investing services | Finance |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
E*TRADE Bank
 E*TRADE Bank Regional BanksFinance Provides banking services | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Williams College
 Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Federal Deposit Insurance Corp.
 Federal Deposit Insurance Corp. Insurance Brokers/ServicesFinance Operates as an insurance agency | Finance |
ETB Holdings, Inc.
 ETB Holdings, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Flamel Technologies, Inc. | |
The National Science Board | |
Cellphire, Inc.
Cellphire, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that develops platelet-derived therapeutics | Commercial Services |
Longeveron, Inc.
 Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Global Life Technologies Corp.
Global Life Technologies Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
NRX Pharmaceuticals, Inc.
 NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company | Health Technology |
Icapath, Inc.
Icapath, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technology that combines PLGA nanoparticles | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
